Press Releases

News

Registration Now Open for the 2018 Empire State Ride To End Cancer

Registration for the 2018 Empire State Ride is now open. This year’s event anticipates more than 200 individuals from across the country will embark on this fully supported, 500+ mile, seven-day bicycling event across New York State with one mission: to end cancer.
News

Sabres and Roswell Park Team Up to Offer Free Prostate Cancer Early Detection Clinic Nov. 14 at KeyBank Center

Roswell Park and the Buffalo Sabres are teaming up to offer free prostate cancer early detection for eligible men. The Nov. 14 event, the latest in the joint One Team, One Goal: Together to Beat Cancer initiative, is part of an ongoing effort to reduce cancer’s impact among the team’s fans through prevention, education and early detection.
News

‘Super T Cells’ Engineered for Optimal Performance Drive New Roswell Park Gene-Therapy Approach

Researchers at Roswell Park Comprehensive Cancer Center have initiated a clinical trial based on a unique two-pronged strategy for arming the immune system to more effectively attack cancer cells. Patients treated through this early-stage clinical trial, which is available only at Roswell Park, will receive one-time injections of their own cells —“super T cells” reprogrammed to make them more effective at targeting tumor cells, and armed with an added element to help them to evade one of cancer’s most resilient defenses.
News

Sustained Top 5% Ranking for Inpatient Satisfaction Earns Roswell Park A Coveted National Distinction

Roswell Park Comprehensive Cancer Center has again been honored by the Press Ganey organization for consistent superior performance in the area of patient experience. The comprehensive cancer center has received Press Ganey’s Guardian of Excellence Award for the third year in a row based on its sustained ranking among the top 5% of hospitals for patient satisfaction related to inpatient care.

News

Viral Vector Mobilan Offers a New Approach for Cancer Immunotherapy

One of the most important areas of cancer research today involves efforts to expand the benefits of immunotherapy to more patients. Research conducted by scientists at Roswell Park Comprehensive Cancer Center in cooperation with Panacela Labs LLC, a subsidiary of Cleveland BioLabs LLC (Nasdaq: CBLI), introduces a new class of immunotherapy and proposes a strategy for increasing the number of patients who are likely to benefit from this new approach.